Navigation Links
Streamline Health Appoints Jay D. Miller to Board of Directors
Date:2/26/2009

CINCINNATI, Feb. 26 /PRNewswire-FirstCall/ -- Streamline Health Solutions, Inc. (Nasdaq: STRM) announced today that Jay D. Miller has been appointed to the Company's Board of Directors. The addition of Mr. Miller brings to five the number of independent members on the Streamline Health Board of Directors.

Mr. Miller has spent roughly 25 years in the medical technology industry with executive-level product development; sales and marketing; and profit and loss responsibilities. Most recently, from 2002 to 2008, Mr. Miller served as president and chief executive officer of Vital Images, Inc., (Nasdaq: VTAL), a leading provider of enterprise-wide advanced visualization and analysis software solutions. Under Mr. Miller's leadership the company experienced significant revenue, net income and market capitalization growth. Prior to becoming president and CEO of Vital Images, Mr. Miller served as their vice president of marketing and business development. Earlier in his career, Mr. Miller was instrumental in the global growth of General Electric's Magnetic Resonance (MR) business and in the development and execution of GE Medical Systems' strategic plan for cardiology in the Americas. Prior to GE, Mr. Miller served at Siemens Medical Systems as a product specialist providing technical marketing and sales support for Siemens' MR products. Mr. Miller has a bachelor's degree in chemistry from Dartmouth College, a master's degree in biomedical engineering from the University of Virginia and a master's degree in management from the Kellogg School of Management at Northwestern University.

J. Brian Patsy, president and CEO of Streamline Health, commented, "We are pleased that Jay Miller has agreed to join our Board a
'/>"/>

SOURCE Streamline Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Greenway Medical Technologies and Navicure Form Partnership to Streamline Claims Management Process
2. Covidien Canada Streamlines Integration and Processing of Fax-based Orders With GHX G-Fax(TM) Fax Conversion Service
3. AVG Anti-Virus and Walling Data Streamline Network Security for National Medical Supply Company
4. Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies
5. BrainLAB, Inc. Announces New, Streamlined Surgery Business Division
6. Streamline Health Solutions, Inc. Reports Third Quarter Results
7. Streamline Health to Integrate Document Workflow Solutions Into Leading Great Lakes Region Hospital System
8. John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers
9. Streamline Health(R) Announces Massena Memorial Hospital to Implement Enterprise Document Workflow Solutions
10. Streamline Health Reschedules Q3 Financial Results Release and Conference Call for Monday, December 15, 2008
11. Streamline Health Announces Appointment of Interim Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 2Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 3Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 4Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 5Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 6Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 7Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 8Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 9Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 10Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 11Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 12Health News:Shaklee Hits the Road with its Infinite Possibilities Tour in New York, NY 2Health News:Kids and Their Families Are Hit Hardest During Flu Season, According to Thomson Reuters Study 2Health News:Taking Statins Faithfully Lengthens Life 2Health News:U.S. Preventive Medicine(R), The Mount Sinai Medical Center Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services 2Health News:U.S. Preventive Medicine(R), The Mount Sinai Medical Center Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services 3Health News:Painkiller Abuse Increases Among Young Adults 2
Breaking Medicine Technology:China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Vivakor Announces New Acquisition Strategy 2General anesthetics lead to learning disabilities in animal models 59954 1General anesthetics lead to learning disabilities in animal models 59954 2General anesthetics lead to learning disabilities in animal models 59954 3New artificial enzyme safer for nature 10482 1New artificial enzyme safer for nature 10482 2Now hear this 10478 1